Respiratory Distress Syndrome: all 1,619 studies
Page 9 of 17. Open to participants first (319), then studies with results posted, then the rest; newest registration first within each.
- Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 PandemiaTerminatedNCT04609865Phase 3
- PRONing to Facilitate Weaning From ECMO in Patients With Refractory Acute Respiratory Distress SyndromeCompletedNCT04607551Not applicable
- Mechanism of Delayed Neutrophil Apoptosis in Acute Lung InjuryCompletedNCT04607434
- Electrical Impedance Tomography Monitoring and Invasive Mechanical Ventilation During Pronation in Acute Respiratory Distress Syndrome.Status unknownNCT04605133
- Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04603755
- A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDSCompletedNCT04602104Phase 1/2
- Survival Rates and Longterm Outcomes After COVID-19CompletedNCT04601090
- Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress SyndromeStatus unknownNCT04597853
- Senicapoc in COVID-19 Patients With Severe Respiratory InsufficiencyStatus unknownNCT04594668Phase 2
- The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19WithdrawnNCT04588441Phase 2
- Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19Status unknownNCT04586114
- A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDSCompletedNCT04582201Phase 1
- Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 PatientsStatus unknownNCT04581161Not applicable
- Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICUCompletedNCT04569266Not applicable
- Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19Status unknownNCT04568018
- Pre-operative Carriage of Respiratory VIRUSes, and Acute Respiratory Distress Syndrome After Heart SurgeryCompletedNCT04562207Not applicable
- Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19Status unknownNCT04556864
- Use of Extracorporeal CO2 Removal in Case of Moderate to Severe ARDS to Apply an Ultraprotective Mechanical Ventilation StrategyTerminatedNCT04556578Not applicable
- Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)Status unknownNCT04552821
- Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)CompletedNCT04548739
- Effect of R-spondin3 on Sepsis Induced Endothelial DysfunctionStatus unknownNCT04546919
- Trial of Therapeutic Hypothermia in Patients With ARDSActive, not recruitingNCT04545424Phase 2
- Earliest Lung Ultrasound Time for Predicting the Need of SurfactantCompletedNCT04544514
- The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term OutcomeCompletedNCT04542538
- Radiomics Markers to Predict Sepsis Induced Acute Respiratory Distress SyndromeStatus unknownNCT04541264
- The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying CauseCompletedNCT04537351Phase 1
- Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)CompletedNCT04534569
- Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With ARDSStatus unknownNCT04530188Phase 3
- MSC-based Therapy in COVID-19-associated Acute Respiratory Distress SyndromeStatus unknownNCT04525378Phase 1
- COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2Status unknownNCT04524156Not applicable
- Prevalence and Kinetics of Diaphragmatic Dysfunction in Elderly Patients With Acute Respiratory DistressCompletedNCT04520815
- Blood Volume Assessment in COVID-19 and Bacterial SepsisCompletedNCT04517695
- Coronavirus Studied by Metagenomics in ARDS COVID-19 PatientsStatus unknownNCT04516486
- Nebulised Heparin to Reduce COVID-19 Induced Acute Lung InjuryCompletedNCT04511923Phase 1/2
- Telmisartan in Respiratory Failure Due to COVID-19CompletedNCT04510662Phase 2
- Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS PatientsWithdrawnNCT04508933
- The Effect pf Goal-directed De-escalation in ARDS on Organ Function and MortalityCompletedNCT04508296Not applicable
- Helmet vs Face Mask in Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04507802Not applicable
- The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic ToolCompletedNCT04506203Not applicable
- Comparison of the Results of Transcutaneous Carbon Dioxide and Oxygen Pressure in Premature Neonates Who Underwent MIST Under HHHFNC or Nasal CPAP MethodsStatus unknownNCT04505176
- Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress SyndromeStatus unknownNCT04503876Not applicable
- Routine Or Selective Application of a Face Mask for Preterm Infants at Birth: the ROSA TrialCompletedNCT04500353Not applicable
- Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19)Status unknownNCT04497454Not applicable
- Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19WithdrawnNCT04490486Phase 1
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill PatientsActive, not recruitingNCT04488081Phase 2
- Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2Status unknownNCT04486729
- Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDSWithdrawnNCT04482712Phase 1/2
- Safety and Effectiveness Assessment of the MakAir Artificial VentilatorTerminatedNCT04475185Not applicable
- Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 InfectionCompletedNCT04475068
- Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance TomographyCompletedNCT04473300
- Assessment of Preload Responsiveness in ARDS Patients During Prone PositionCompletedNCT04457739
- One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19CompletedNCT04457505
- Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19Active, not recruitingNCT04456361Early Phase 1
- Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)WithdrawnNCT04453371Phase 3
- Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDSWithdrawnNCT04452097Phase 1/2
- Study of Decidual Stromal Cells to Treat COVID-19 Respiratory FailureCompletedNCT04451291Not applicable
- Knowledge, Attitude and Practice of Dental Students About COVID-19CompletedNCT04449081
- Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress SyndromeCompletedNCT04447833Phase 1
- Inhaled Iloprost for Suspected COVID-19 Respiratory FailureCompletedNCT04445246Phase 2
- PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected CohortCompletedNCT04444609
- Glycine Supplement for Severe COVID-19TerminatedNCT04443673Not applicable
- Comparison of Esophageal and Central Venous Pressure for Estimating Transpulmonary Pressure ChangesCompletedNCT04443491
- Effectiveness of Convalescent Immune Plasma TherapyCompletedNCT04442958Not applicable
- EIT in Patient Ventilator AsynchronyCompletedNCT04442815
- Universal Anti-Viral Vaccine for Healthy Elderly AdultsCompletedNCT04441047Phase 1/2
- Chest Physiotherapy in Tracheotomized PatientsCompletedNCT04435535Not applicable
- Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19Status unknownNCT04435353Not applicable
- Physical Rehabilitation in ICU in ARDS Patients With COVID-19CompletedNCT04435080
- Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).TerminatedNCT04433546Phase 2
- Early Prone Position on Coronavirus Disease 2019 PneumoniaCompletedNCT04427969
- External Dead Space in Ventilated COVID-19 PatientsCompletedNCT04424082Not applicable
- Characterization of Persistent Pulmonary Abnormalities Following COVID-19 PneumoniaCompletedNCT04422613Not applicable
- Driving Pressure and Mortality: in the Pediatric Intensive Care Unit (PICU)CompletedNCT04419376
- This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)TerminatedNCT04417036Phase 2
- Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19Status unknownNCT04416139Phase 2
- Echocardiography in Patients With Covid-19WithdrawnNCT04412460
- Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 DiseaseStatus unknownNCT04412395Phase 2
- Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04411459
- Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory FailureStatus unknownNCT04411368
- The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST)Status unknownNCT04409665Phase 1
- Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04408326
- Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope - the VISUAL MethodCompletedNCT04406142Not applicable
- Effects of Non-invasive Ventilation With Helium-oxygen Mixture in Premature Infants With Respiratory Distress SyndromeCompletedNCT04404816Phase 1/2
- CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04404426Not applicable
- CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate GoalsCompletedNCT04402879Not applicable
- Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)CompletedNCT04402840Not applicable
- Effectiveness of Bubble Nasal Continuous Positive Airway Pressure (bCPAP) in Neonatal Respiratory DistressCompletedNCT04401696Not applicable
- Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium NitriteWithdrawnNCT04401527Phase 2
- Using GM-CSF as a Host Directed Therapeutic Against COVID-19CompletedNCT04400929Phase 2
- Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04400032Phase 1/2
- Nebulized Heparin for the Treatment of COVID-19 Induced Lung InjuryTerminatedNCT04397510Phase 4
- Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)Status unknownNCT04397497Phase 2
- A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)Status unknownNCT04395456Phase 2
- COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEssCompletedNCT04395144Not applicable
- Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical TrialTerminatedNCT04395105Phase 3
- The Critical Care Response to the COVID-19 Pandemic in MadridStatus unknownNCT04393324
- Cerebral and Circulatory Effects of Neonatal Volume Targeted VentilationCompletedNCT04391634Not applicable
- Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDSStatus unknownNCT04391140Not applicable
- Smartphone Application for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space ReductionStatus unknownNCT04390360Not applicable
- Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19TerminatedNCT04390152Phase 1/2